Biotechnology, Definitions, Scope and Historical Trajectory

The dot point instructs you to investigate the uses and applications of biotechnology past, present and future — a scoping instruction rather than a written task, so it is examined with Analyse — investigate → analyse. The three time periods are the structure the dot point supplies.

Plan: identify the components, state the constraint that links them, relate them across the three periods, then draw the implication and its limits.

Biotechnology is the use of living organisms or their components to make a product or process useful to humans. Every application, ancient or modern, can be described by three things: the organism used, the level at which it is manipulated, and the precision with which the outcome can be specified in advance.

Those three are linked by what was understood at the time. Manipulation cannot be more precise than the knowledge of the mechanism being manipulated, so the trajectory of biotechnology tracks the trajectory of genetics rather than of engineering — each jump in precision follows a discovery about how inheritance works, not a new machine.

Past applications manipulated whole organisms without knowing why they worked: fermentation using yeast, and selective breeding, which changed allele frequencies over generations by choosing which individuals reproduced. Present applications manipulate DNA directly, and with the discovery of restriction enzymes and the structure of DNA the unit of manipulation shifted from the organism to the gene — so a human insulin gene can be placed into a bacterium and the outcome specified precisely. Emerging applications manipulate a chosen sequence within a genome, as CRISPR-based editing does, moving the unit from the gene to the base.

The trend has limits worth stating. Precision of technique has advanced faster than the ability to predict biological consequence, so an edit can be made exactly as intended and still produce an unexpected phenotype through off-target effects or gene interactions. And the older methods have not been replaced — selective breeding still produces most of the world's crop improvement, so the trajectory describes what is newly possible rather than what is mostly done.

It follows that the direction of change has been towards smaller units of manipulation and greater specificity of outcome, so future applications are most likely where a desired change can be localised to a known sequence — single-gene disorders, for example — and least likely where the trait is polygenic and environmentally modified. The trajectory predicts the shape of what comes next better than it predicts the timing.

Compare requires similarities and differences against stated criteria. Two descriptions in sequence, however accurate, will not score as a comparison.

Plan: state the criteria, establish what the two share, then take each criterion across both.

Both aim to produce an organism with a characteristic humans want, both change the organism's genetic make-up, and both are therefore forms of biotechnology; the results of both are heritable. They will be compared on the source of the new characteristic, the precision and speed of the change, and the species barrier.

Selective breeding can only work with variation already present in the species or in one closely related enough to interbreed, so the characteristic must already exist somewhere in that gene pool. Recombinant DNA technology introduces a gene from any organism, so the characteristic need not have existed in the species at all — which is why a bacterium can be made to produce human insulin and no amount of breeding could achieve it.

Selective breeding changes the whole genome at once. Every cross carries thousands of genes along with the selected one, so unwanted traits are inherited alongside desired ones, and because the change accumulates over generations it takes years to decades. Recombinant DNA technology transfers a single identified gene and can produce a modified organism within one generation, so it is both more precise and far faster.

The two also differ in what limits them. Selective breeding is limited by reproductive compatibility, so it cannot cross a species barrier; recombinant technology is limited instead by knowing which gene to move and whether the recipient will express it correctly. The constraint shifts from biology to knowledge, which is why the newer method's failures are usually failures of prediction rather than of crossing.

The comparison shows the two are not simply older and newer versions of one thing. Selective breeding remains better suited to polygenic traits such as yield or drought tolerance, where no single gene can be identified to move, while recombinant technology is better suited to single-gene traits — so which is superior depends on the genetic architecture of the characteristic wanted.